NEW SILK ROUTE
NEW SILK ROUTE is a Series C+ fund in the US, india and asia investing in Fintech, Healthcare, telecommunications, education, media, pharmaceuticals, manufacturing, renewable-energy, consumer-services, energy-infrastructure and discovery-tools.
- Stages
- Series C+
- Sectors
- Fintech, Healthcare, telecommunications, education, media, pharmaceuticals, manufacturing, renewable-energy, consumer-services, energy-infrastructure, discovery-tools
- Invests in
- US-wide, india, asia
- Actively investing
- Yes
- Founded
- 2006
- Assets under management
- $1 billion
- Website
- nsrpartners.com
Check size not disclosed
Thesis
New Silk Route (NSR) is a growth capital firm established in 2006, primarily investing in private companies within the Indian subcontinent and other rapidly growing economies in Asia, with some focus on North America. The firm targets a diverse range of sectors including healthcare, telecommunications, education, financial services, media, pharmaceuticals, manufacturing, renewable energy, and consumer services. NSR's strategy centers on providing growth capital to companies with strong potential for scalability and operational improvement, often taking control positions to drive growth. They primarily invest in growth-stage companies. As of March 2026, the firm had a portfolio of 9 companies and $1 billion in AUM, with total registered AUM of $531,530,183 as of March 26, 2026. Ltd., Vasudev Adiga's Fast Food, VRL Logistics, 9X Media, Café Coffee Day, Ammonix, Moshes Fine Foods, Alloy Therapeutics, and Kiran Energy.
Common questions
Does NEW SILK ROUTE invest at the Series C+ stage?
Yes. NEW SILK ROUTE lists Series C+ among the stages it invests in.
Where does NEW SILK ROUTE invest?
NEW SILK ROUTE invests in the US, india and asia.